BioCentriq
Newark
About BioCentriq
BioCentriq is the cell and gene therapy development and manufacturing center. Leveraging state-of-the-art facilities, cutting-edge technologies, and a team of seasoned professionals, the company has a demonstrated history of effectively transferring, developing and manufacturing GMP drug products for clinical trial use. BioCentriq is committed to driving innovation in cell therapy and assisting its partners in delivering transformative treatments to patients globally.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $29.2M
- Funding stage: M&A
- Last round: Series A (Jan 2024)
- Website: biocentriq.com
- Phone: 973-642-7999
Industries & Categories
Biotechnology, Genetics, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/biocentriq-91619 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.